Nature Medicine
Close windowclose window
Figure 2

Nature Medicine  9, 448 - 452 (2003)
Published online: 17 March 2003; | doi:10.1038/nm840

Neuropathology of human Alzheimer disease after immunization with amyloid-bold beta peptide: a case report

James A.R. Nicoll, David Wilkinson, Clive Holmes, Phil Steart, Hannah Markham & Roy O. Weller
 
Fig 2 full size
Figure 2. Distribution of other features of AD pathology in relation to Abeta plaques and association of Abeta with microglia.
ad, In the immunized case, cortical areas with abundant Abeta plaques (a) (corresponding sections immunostained for tau protein (b)) have plaque-associated dystrophic neurites, neurofibrillary tangles and neuropil threads similar to unimmunized AD. In contrast, cortical areas devoid of Abeta plaques (c) when immunostained for tau protein (d) have neurofibrillary tangles and neuropil threads but lack clusters of dystrophic neurites. Persistence of vascular Abeta (CAA) can be seen in area devoid of Abeta plaques (c; top left). e, Interface between plaque-bearing cortex (right) and area devoid of plaques (left), showing unusual punctate immunoreactivity for Abeta (arrow). f and g, Higher-powered view of an area of parietal neocortex devoid of plaques (f). This area shows punctate immunoreactivity for Abeta, which takes the form of clusters of granules and appears very similar to an adjacent section (g) immunostained with an antibody against lysosomes of phagocytic microglia (CD68). h, Negative control for the corresponding area, without primary antibody.

 
Previous | Next 
Close windowclose window
©2007 Nature Publishing Group | Privacy policy